7Baggers
 Rx Rundown: Metagenomi, Chiesi, Thermo Fisher Scientific and more  Medical Marketing and Media Fri, 14 Nov 2025 23:01:02 GMT
 Chutes & Ladders—Ovid eyes next chapter with CEO transition  Fierce Biotech Fri, 14 Nov 2025 13:30:00 GMT
 Metagenomi culls 25% of its workforce and replaces CEO in reshuffle  Pharmaceutical Technology Thu, 13 Nov 2025 18:00:00 GMT
 Chardan Cuts Price Target on Metagenomi to $7 From $11, Keeps Buy Rating  MarketScreener Thu, 13 Nov 2025 13:58:26 GMT
 Metagenomi, Inc. Reports Q3 2025 Financial Results  TipRanks Thu, 13 Nov 2025 04:46:41 GMT
 Metagenomi price target lowered to $7 from $11 at Chardan  TipRanks Wed, 12 Nov 2025 23:11:50 GMT
 Metagenomi’s CEO exit, workforce cuts; Cogent’s $475M+ raise  Endpoints News Wed, 12 Nov 2025 15:14:00 GMT
 metagenomi’s workforce cuts; cogent’s $475m+ raise  Endpoints News Wed, 12 Nov 2025 15:14:00 GMT
 CEO shuffle at Ovid, Metagenomi  FirstWord Pharma Wed, 12 Nov 2025 14:11:24 GMT
 Metagenomi Announces Positive Preclinical Data for MGX-001  TipRanks Wed, 12 Nov 2025 14:03:15 GMT
 metagenomi’s mgx-001 shows curative fviii activity in nhps  BioWorld MedTech Wed, 12 Nov 2025 13:00:00 GMT
 TD Cowen Maintains Metagenomi Technologies(MGX.US) With Buy Rating  富途牛牛 Wed, 12 Nov 2025 01:32:00 GMT
 metagenomi (mgx) reports q3 loss, lags revenue estimates  sharewise.com Wed, 12 Nov 2025 01:08:53 GMT
 metagenomi to advance hemophilia a gene therapy to clinical trials  MarketScreener Tue, 11 Nov 2025 22:43:11 GMT
 Metagenomi (MGX) Reports Q3 Loss, Lags Revenue Estimates  Yahoo Finance Tue, 11 Nov 2025 22:10:02 GMT
 Metagenomi shares fall as company cuts workforce, changes CEO  Investing.com Tue, 11 Nov 2025 22:09:13 GMT
 metagenomi: q3 earnings snapshot  San Francisco Chronicle Tue, 11 Nov 2025 21:52:49 GMT
 Metagenomi advances hemophilia A program amid strategic restructuring  Investing.com Tue, 11 Nov 2025 21:46:15 GMT
 Metagenomi reduces workforce by 25%  TipRanks Tue, 11 Nov 2025 21:41:48 GMT
 Metagenomi reports Q3 EPS (55c), consensus (53c)  TipRanks Tue, 11 Nov 2025 21:38:31 GMT
 Metagenomi Reports Third Quarter 2025 Financial Results and  GlobeNewswire Tue, 11 Nov 2025 21:02:00 GMT
 Metagenomi, Inc. Announces CEO Changes  MarketScreener Tue, 11 Nov 2025 21:02:00 GMT
 Metagenomi, Inc. to Appoint Willard Dere as New Board Chair  MarketScreener Tue, 11 Nov 2025 21:02:00 GMT
 Metagenomi Presents New Preclinical Data from MGX-001  GlobeNewswire Tue, 11 Nov 2025 21:01:00 GMT
 Metagenomi Speeds Its Gene Editing Research with AWS, AI  HPCwire Fri, 07 Nov 2025 08:00:00 GMT
 td cowen maintains metagenomi technologies(mgx.us) with buy rating  富途牛牛 Sun, 02 Nov 2025 07:00:00 GMT

Metagenomi Inc.
(NASDAQ:MGX) 

MGX stock logo

Metagenomi, Inc., a gene editing biotechnology company, develops therapeutics for patients using metagenomics-derived genome editing toolbox in the United States. The company is headquartered in Emeryville, California.

Founded: 2018
CEO / Founder: Brian C. Thomas 
Sector: TECHNOLOGY
Industry: GENERAL

Share this website to your friends